{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:23:43Z","timestamp":1780611823767,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.thromres.2025.109397","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T11:13:57Z","timestamp":1751714037000},"page":"109397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparison of rivaroxaban with warfarin for intracardiac thrombosis in the pediatric population at different cardiac sites: Early experience of anticoagulation approach and treatment outcomes"],"prefix":"10.1016","volume":"253","author":[{"given":"Deborah","family":"Cappelletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bucciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Bordignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Di Cesare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Bucciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bacchiocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Manini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Merlino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Filippelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Lionetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6 Suppl","key":"10.1016\/j.thromres.2025.109397_bb0005","doi-asserted-by":"crossref","first-page":"887S","DOI":"10.1378\/chest.08-0762","article-title":"Antithrombotic therapy in neonates and children: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)","volume":"133","author":"Monagle","year":"2008","journal-title":"Chest"},{"issue":"2 Suppl","key":"10.1016\/j.thromres.2025.109397_bb0010","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.thromres.2025.109397_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102266","article-title":"Intracardiac thrombi in pediatrics: anticoagulation approach and treatment outcomes","volume":"7","author":"Agarwal","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109397_bb0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40119-021-00228-4","article-title":"Thrombosis prevention and anticoagulation Management in the Pediatric Patient with congenital heart disease","volume":"10","author":"Abdelghani","year":"2021","journal-title":"Cardiol. Ther."},{"issue":"24","key":"10.1016\/j.thromres.2025.109397_bb0025","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1161\/01.cir.0000436140.77832.7a","article-title":"Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association","volume":"128","author":"Giglia","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.thromres.2025.109397_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa181","article-title":"Novel oral anticoagulants in intracardiac thrombosis resolution: a case series","volume":"4","author":"Al-Sadawi","year":"2020","journal-title":"Eur. Heart J. Case Rep."},{"key":"10.1016\/j.thromres.2025.109397_bb0035","series-title":"Manual of Pediatric Cardiac Care","first-page":"415","article-title":"Anticoagulation","author":"Alakeel","year":"2024"},{"issue":"4","key":"10.1016\/j.thromres.2025.109397_bb0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1590\/1984-0462\/;2017;35;4;00008","article-title":"Use of warfarin in pediatrics: clinical and pharmacological characteristics","volume":"35","author":"Santos","year":"2017","journal-title":"Rev. Paul. Pediatr."},{"issue":"15","key":"10.1016\/j.thromres.2025.109397_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001092","article-title":"Management of patients at risk for and with left ventricular thrombus: a scientific statement from the American Heart Association","volume":"146","author":"Levine","year":"2022","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.thromres.2025.109397_bb0050","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2022.09.031","article-title":"Edoxaban for thromboembolism prevention in pediatric patients with cardiac disease","volume":"80","author":"Portman","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2025.109397_bb0055","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.thromres.2023.12.019","article-title":"Anticoagulation of pediatric patients with venous thromboembolism in 2023","volume":"235","author":"van Ommen","year":"2024","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2025.109397_bb0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.thromres.2010.09.008","article-title":"The mechanism of action of rivaroxaban--an oral, direct factor Xa inhibitor--compared with other anticoagulants","volume":"127","author":"Samama","year":"2011","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2025.109397_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0167-5273(93)90008-5","article-title":"Intracardiac thrombosis diagnosed by echocardiography in childhood: predisposing and etiological factors","volume":"40","author":"Ozkutlu","year":"1993","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.thromres.2025.109397_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MBC.0b013e3283333c7c","article-title":"Neonatal and childhood right atrial thrombosis: recognition and a risk-stratified treatment approach","volume":"21","author":"Yang","year":"2010","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"07","key":"10.1016\/j.thromres.2025.109397_bb0075","first-page":"157","article-title":"Recommendations for tPA thrombolysis in children","volume":"88","author":"Wang","year":"2017","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2025.109397_bb0080","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/CCM.0000000000004025","article-title":"Bleeding assessment scale in critically ill children (BASIC): physician-driven diagnostic criteria for bleeding severity","volume":"47","author":"Nellis","year":"2019","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.thromres.2025.109397_bb0085","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109397_bb0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpeds.2016.02.017","article-title":"Incidence trends and mortality from childhood venous thromboembolism: a population-based cohort study","volume":"172","author":"Sabapathy","year":"2016","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.thromres.2025.109397_bb0095","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mpd.2001.118192","article-title":"Venous thromboembolism in childhood: a prospective two-year registry in the Netherlands","volume":"139","author":"van Ommen","year":"2001","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.thromres.2025.109397_bb0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11886-001-0016-y","article-title":"Congenital heart disease: current indications for antithrombotic therapy in pediatric patients","volume":"3","author":"Reller","year":"2001","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.thromres.2025.109397_bb0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.thromres.2022.11.027","article-title":"Real world experience of efficacy and safety of rivaroxaban in paediatric venous thromboembolism","volume":"221","author":"Hassan","year":"2023","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2025.109397_bb0110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/jth.15260","article-title":"International pediatric thrombosis network to advance pediatric thrombosis research: communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis","volume":"19","author":"van Ommen","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109397_bb0115","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/jth.14813","article-title":"Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluation","volume":"18","author":"Young","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109397_bb0120","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109397_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2352-4642(21)00343-6","article-title":"Direct oral anticoagulants for use in paediatrics","volume":"6","author":"Jaffray","year":"2022","journal-title":"Lancet Child Adolesc. Health"},{"issue":"11","key":"10.1016\/j.thromres.2025.109397_bb0130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/14779072.2020.1823218","article-title":"Rivaroxaban for the treatment of venous thromboembolism in pediatric patients","volume":"18","author":"Cohen","year":"2020","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"3","key":"10.1016\/j.thromres.2025.109397_bb0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/j.ajkd.2023.08.017","article-title":"Comparative safety and effectiveness of warfarin or rivaroxaban versus Apixaban in patients with advanced CKD and atrial fibrillation: nationwide US cohort study","volume":"83","author":"Fu","year":"2024","journal-title":"Am. J. Kidney Dis."},{"issue":"10","key":"10.1016\/j.thromres.2025.109397_bb0140","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1016\/j.jtha.2023.07.011","article-title":"Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis","volume":"21","author":"Giossi","year":"2023","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825001471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:28:37Z","timestamp":1761406117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825001471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":28,"alternative-id":["S0049384825001471"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109397","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of rivaroxaban with warfarin for intracardiac thrombosis in the pediatric population at different cardiac sites: Early experience of anticoagulation approach and treatment outcomes","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109397"}}